Loading organizations...
Loading organizations...
Developing therapies to target cancer's immune evasion mechanisms.
Kurome Therapeutics has raised $15.0M across 1 funding round.
Kurome Therapeutics has raised $15.0M in total across 1 funding round.
Kurome Therapeutics has raised $15.0M in total across 1 funding round.
Kurome Therapeutics's investors include Daniel Heller, Aaron Kantoff, CincyTech.
Kurome Therapeutics has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 10, 2021 | $15.0M Series A | Daniel Heller, Aaron Kantoff | CincyTech |